185 related articles for article (PubMed ID: 1512239)
21. Isolation and characterization of thrombin-activated human factor VIII.
Curtis JE; Helgerson SL; Parker ET; Lollar P
J Biol Chem; 1994 Feb; 269(8):6246-51. PubMed ID: 8119969
[TBL] [Abstract][Full Text] [Related]
22. The role of electrostatic interactions in the assembly of the factor X activating complex on both activated platelets and negatively-charged phospholipid vesicles.
London F; Walsh PN
Biochemistry; 1996 Sep; 35(37):12146-54. PubMed ID: 8810922
[TBL] [Abstract][Full Text] [Related]
23. Structural insights into the interaction of blood coagulation co-factor VIIIa with factor IXa: a computational protein-protein docking and molecular dynamics refinement study.
Venkateswarlu D
Biochem Biophys Res Commun; 2014 Sep; 452(3):408-14. PubMed ID: 25157807
[TBL] [Abstract][Full Text] [Related]
24. Interactions between residues 2228-2240 within factor VIIIa C2 domain and factor IXa Gla domain contribute to propagation of clot formation.
Soeda T; Nogami K; Ogiwara K; Shima M
Thromb Haemost; 2011 Nov; 106(5):893-900. PubMed ID: 21947241
[TBL] [Abstract][Full Text] [Related]
25. Localization of factor IXa and factor VIIIa interactive sites.
O'Brien LM; Medved LV; Fay PJ
J Biol Chem; 1995 Nov; 270(45):27087-92. PubMed ID: 7592960
[TBL] [Abstract][Full Text] [Related]
26. SAXS analysis of the intrinsic tenase complex bound to a lipid nanodisc highlights intermolecular contacts between factors VIIIa/IXa.
Childers KC; Peters SC; Lollar P; Spencer HT; Doering CB; Spiegel PC
Blood Adv; 2022 Jun; 6(11):3240-3254. PubMed ID: 35255502
[TBL] [Abstract][Full Text] [Related]
27. X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.
Brandstetter H; Bauer M; Huber R; Lollar P; Bode W
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9796-800. PubMed ID: 7568220
[TBL] [Abstract][Full Text] [Related]
28. Identification of residues Asn89, Ile90, and Val107 of the factor IXa second epidermal growth factor domain that are essential for the assembly of the factor X-activating complex on activated platelets.
Yang X; Chang YJ; Lin SW; Walsh PN
J Biol Chem; 2004 Nov; 279(45):46400-5. PubMed ID: 15328360
[TBL] [Abstract][Full Text] [Related]
29. Cofactor activity in factor VIIIa of the blood clotting pathway is stabilized by an interdomain bond between His281 and Ser524 formed in factor VIII.
Wakabayashi H; Monaghan M; Fay PJ
J Biol Chem; 2014 May; 289(20):14020-9. PubMed ID: 24692542
[TBL] [Abstract][Full Text] [Related]
30. Annexin V inhibition of factor IXa-catalyzed factor X activation on human platelets and on negatively-charged phospholipid vesicles.
London F; Ahmad SS; Walsh PN
Biochemistry; 1996 Dec; 35(51):16886-97. PubMed ID: 8988028
[TBL] [Abstract][Full Text] [Related]
31. Role of the C2 domain of factor VIIIa in the assembly of factor-X activating complex on the platelet membrane.
Ahmad SS; Walsh PN
Biochemistry; 2005 Oct; 44(42):13858-65. PubMed ID: 16229474
[TBL] [Abstract][Full Text] [Related]
32. Factor VIII A3 domain residues 1793-1795 represent a factor IXa-interactive site in the tenase complex.
Takeyama M; Furukawa S; Sasai K; Horiuchi K; Nogami K
Biochim Biophys Acta Gen Subj; 2023 Aug; 1867(8):130381. PubMed ID: 37207906
[TBL] [Abstract][Full Text] [Related]
33. Molecular models of the procoagulant factor VIIIa-factor IXa complex.
Autin L; Miteva MA; Lee WH; Mertens K; Radtke KP; Villoutreix BO
J Thromb Haemost; 2005 Sep; 3(9):2044-56. PubMed ID: 16102111
[TBL] [Abstract][Full Text] [Related]
34. Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.
Panteleev MA; Saenko EL; Ananyeva NM; Ataullakhanov FI
Biochem J; 2004 Aug; 381(Pt 3):779-94. PubMed ID: 15104540
[TBL] [Abstract][Full Text] [Related]
35. Residues 88-109 of factor IXa are important for assembly of the factor X activating complex.
Wilkinson FH; London FS; Walsh PN
J Biol Chem; 2002 Feb; 277(8):5725-33. PubMed ID: 11726655
[TBL] [Abstract][Full Text] [Related]
36. Factor VIII-driven changes in activated factor IX explored by hydrogen-deuterium exchange mass spectrometry.
Freato N; Ebberink EHTM; van Galen J; Fribourg C; Boon-Spijker M; van Alphen FPJ; Meijer AB; van den Biggelaar M; Mertens K
Blood; 2020 Dec; 136(23):2703-2714. PubMed ID: 32678887
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of factor VIII by factor IXa.
O'Brien DP; Johnson D; Byfield P; Tuddenham EG
Biochemistry; 1992 Mar; 31(10):2805-12. PubMed ID: 1547220
[TBL] [Abstract][Full Text] [Related]
38. An ordered sequential mechanism for Factor IX and Factor IXa binding to platelet receptors in the assembly of the Factor X-activating complex.
Yang X; Walsh PN
Biochem J; 2005 Aug; 390(Pt 1):157-67. PubMed ID: 15755260
[TBL] [Abstract][Full Text] [Related]
39. Factor VIII mutated with Lys1813Ala within the factor IXa-binding region enhances intrinsic coagulation potential.
Nakajima Y; Takeyama M; Oda A; Shimonishi N; Nogami K
Blood Adv; 2023 Apr; 7(8):1436-1445. PubMed ID: 36322904
[TBL] [Abstract][Full Text] [Related]
40. Nonasaccharide Inhibits Intrinsic Factor Xase Complex by Binding to Factor IXa and Disrupting Factor IXa-Factor VIIIa Interactions.
Xiao C; Zhao L; Gao N; Wu M; Zhao J
Thromb Haemost; 2019 May; 119(5):705-715. PubMed ID: 30900221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
